These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.
    Author: Shah VA, Gupta SK, Shah KV, Vinjamaram S, Chalam KV.
    Journal: Ophthalmic Epidemiol; 2004 Feb; 11(1):43-51. PubMed ID: 14977496.
    Abstract:
    PURPOSE: To evaluate the utility scores in patients with varying degrees of visual morbidity due to diabetic retinopathy or ARMD. METHODS: Patients with vision < or =20/40 in one eye due to diabetic retinopathy or ARMD were enrolled. Utility scores were measured by the time trade-off (TTO) method after stratifying the patient population with visual impairment in the better eye (group 1, 20/20 to 20/40; group 2, 20/50 to 20/100; group 3, 20/200 to no light perception). RESULTS: Sub-group analysis revealed that subjects in group 1 were willing to give up a median of 1 year as compared to 3 years by the subjects in group 3 for perfect bilateral visual acuity (P<0.05). The median utility score was 0.94 for group 1, 0.96 for group 2 and 0.80 for group 3. While the utility scores for groups 1 and 2 were comparable (P>0.05), there was a significant difference in the utility scores between groups 1 and 3 and between groups 2 and 3 (P<0.05). There was no significant effect on the utility scores of age, educational level or prior ocular surgery. CONCLUSION: Substantial visual loss secondary to diabetic retinopathy or ARMD is associated with a significant decrease in utility scores. However, TTO scores were not sensitive enough to demonstrate a difference between subjects with mild (group 1) and moderate (group 2) visual loss in the better eye secondary to diabetic retinopathy or ARMD.
    [Abstract] [Full Text] [Related] [New Search]